{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:38:29Z","timestamp":1775666309017,"version":"3.50.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The coronavirus disease 19 (COVID-19) pandemic has prompted the development of new vaccines to reduce the morbidity and mortality associated with this disease. Recognition and report of potential adverse effects of these novel vaccines (especially the urgent and life-threatening ones) is therefore essential.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 16-year-old boy presented to the Paediatric Emergency Department with polyuria, polydipsia and weight loss over the last four months. His past medical history was unremarkable. Onset of symptoms was referred to be few days after first dose of anti-COVID-19 BNT162b2 Comirnaty vaccine and then worsened after the second dose. The physical exam was normal, without neurological abnormalities. Auxological parameters were within normal limits. Daily fluid balance monitoring confirmed polyuria and polydipsia. Biochemistry laboratory analysis and urine culture were normal. Serum osmolality was 297 mOsm\/Kg H<jats:sub>2<\/jats:sub>O (285-305), whereas urine osmolality was 80 mOsm\/Kg H<jats:sub>2<\/jats:sub>O (100-1100), suggesting diabetes insipidus. Anterior pituitary function was preserved. Since parents refused to give consent to water deprivation test, treatment with Desmopressin was administered and confirmed ex juvantibus diagnosis of AVP deficiency (or central diabetes insipidus). Brain MRI revealed pituitary stalk thickening (4\u00a0mm) with contrast enhancement, and loss of posterior pituitary bright spot on T1 weighted imaging. Those signs were consistent with neuroinfundibulohypophysitis. Immunoglobulin levels were normal. Low doses of oral Desmopressin were sufficient to control patient\u2019s symptoms, normalizing serum and urinary osmolality values and daily fluid balance at discharge. Brain MRI after 2 months showed stable thicken pituitary stalk and still undetectable posterior pituitary. Due to persistence of polyuria and polydipsia, therapy with Desmopressin was adjusted by increasing dosage and number of daily administrations. Clinical and neuroradiological follow-up is still ongoing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Hypophysitis is a rare disorder characterized by lymphocytic, granulomatous, plasmacytic, or xanthomatous infiltration of the pituitary gland and stalk. Common manifestations are headache, hypopituitarism, and diabetes insipidus. To date, only time correlation between SARS-CoV-2 infection and development of hypophysitis and subsequent hypopituitarism has been reported. Further studies will be needed to deepen a possible causal link between anti-COVID-19 vaccine and AVP deficiency.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1166953","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T05:18:42Z","timestamp":1681795122000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: A case report"],"prefix":"10.3389","volume":"14","author":[{"given":"Cristina","family":"Partenope","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quincy","family":"Pedranzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Petri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Rabbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Prodam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Bellone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00484-6","article-title":"Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through nov 14, 2021: A statistical analysis","volume":"399","author":"Barber","year":"2022","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/idr14020023","article-title":"COVID-19 and the endocrine system: A review of the current information and misinformation","volume":"14","author":"Mirza","year":"2022","journal-title":"Infect Dis Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm10030446","article-title":"Multi-organ involvement in covid-19: Beyond pulmonary manifestations","volume":"10","author":"Thakur","year":"2021","journal-title":"J Clin Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endocr\/bqaa108","article-title":"Endocrine significance of SARS-CoV-2\u2019s reliance on ACE2","volume":"161","author":"Lazartigues","year":"2020","journal-title":"Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23526","article-title":"Pfizer-BioNTech COVID-19 vaccine (BNT162b2) side effects: A systematic review","volume":"14","author":"Dighriri","year":"2022","journal-title":"Cureus"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2022.1027047","article-title":"Endocrine system after 2 years of COVID-19 vaccines: A narrative review of the literature","volume":"13","author":"Pezzaioli","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-022-03119-3","article-title":"Influence of COVID-19 vaccines on endocrine system","volume":"78","author":"Zhao","year":"2022","journal-title":"Endocrine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2021.38.222.28243","article-title":"Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of covid-19 infection: A case report","volume":"38","author":"Sheikh","year":"2021","journal-title":"Pan Afr Med J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01387-6","article-title":"Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2","volume":"27","author":"Au","year":"2021","journal-title":"Nat Med [Internet]"},{"key":"B10","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1177\/23247096211043386","article-title":"A case of hypophysitis following immunization with the mRNA-1273 SARS-CoV-2 vaccine","volume":"9","author":"Murvelashvili","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.889074","article-title":"Central diabetes insipidus following immunization with BNT162b2 mRNA COVID-19 vaccine: A case report","volume":"13","author":"Bou\u00e7a","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2022.06.001","article-title":"A case of hypophysitis associated with SARS-CoV-2 vaccination","volume":"8","author":"Ankireddypalli","year":"2022","journal-title":"AACE Clin Case Rep [Internet]"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2021.645787","article-title":"Spectrum of endocrine dysfunction and association with disease severity in patients with COVID-19: Insights from a cross-sectional, observational study","volume":"12","author":"Das","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1177\/2324709621999954","article-title":"Diabetes insipidus and concomitant myocarditis: A late sequelae of COVID-19 infection","volume":"9","author":"Sheikh","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12902-022-01048-w","article-title":"Central diabetes insipidus secondary to COVID-19 infection: a case report","volume":"22","author":"Yavari","year":"2022","journal-title":"BMC Endocr Disord [Internet]"},{"key":"B16","doi-asserted-by":"publisher","first-page":"E448","DOI":"10.1097\/INF.0000000000003632","article-title":"Central diabetes insipidus: Another rare complication of SARS-CoV-2 infection in children","volume":"41","author":"Lizzi","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01627-z","article-title":"Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection","volume":"44","author":"Misgar","year":"2021","journal-title":"J Endocrinol Invest [Internet]"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-22-0056","article-title":"Pituitary apoplexy in the aftermath of a SARS-CoV-2 infection: A case series from amiens university hospital","volume":"187","author":"Balmain","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab302","article-title":"Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease","volume":"144","author":"Balcom","year":"2021","journal-title":"Brain"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-021-09672-y","article-title":"COVID-19 and hypopituitarism","volume":"23","author":"Frara","year":"2022","journal-title":"Rev Endocr Metab Disord [Internet]"},{"key":"B21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.medcle.2021.09.021","article-title":"Case report: Pituitary apoplexy after COVID-19 vaccination","volume":"158","author":"Pinar-Guti\u00e9rrez","year":"2022","journal-title":"Med Clin (Barc)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.hest.2022.04.002","article-title":"Pituitary apoplexy following adenoviral vector-based COVID-19 vaccination","volume":"4","author":"Roncati","year":"2023","journal-title":"Brain Hemorrhages"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-022-01095-3","article-title":"Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: A case report","volume":"22","author":"Morita","year":"2022","journal-title":"BMC Endocr Disord [Internet]"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.12659\/AJCR.936217","article-title":"Neuroleptic malignant syndrome with adrenal insufficiency after BNT162b2 COVID-19 vaccination in a man taking valproate: A case report","volume":"23","author":"Mizuno","year":"2022","journal-title":"Am J Case Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06690-8","article-title":"The syndrome of inappropriate antidiuresis after vaccination against COVID-19: Case report","volume":"21","author":"Lindner","year":"2021","journal-title":"BMC Infect Dis [Internet]"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab373","article-title":"Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: Post- vaccination ASIA syndrome bur\u00e7in","volume":"106","author":"Bur\u00e7in","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines11020434","article-title":"New onset of giant cell arteritis following ChAdOx1-s (Vaxevria\u00ae) vaccine administration","volume":"11","author":"Lo Sardo","year":"2023","journal-title":"Vaccines"},{"key":"B28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4103\/ojo.ojo_354_21","article-title":"Optic neuritis secondary to the pfizer-BioNTech-162b2 COVID-19 vaccine managed with plasmapheresis: A case report and review","volume":"15","author":"Paras","year":"2022","journal-title":"Oman J Ophthalmol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11102-022-01276-2","article-title":"Changing the name of diabetes insipidus","author":"Arima","year":"2022","journal-title":"Pituitary"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1836","article-title":"Normal pituitary stalk: High-resolution MR imaging at 3T","volume":"31","author":"Satogami","year":"2010","journal-title":"Am J Neuroradiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0094","article-title":"Role of MRI T2-DRIVE in the assessment of pituitary stalk abnormalities without gadolinium in pituitary diseases","volume":"178","author":"Elisabetta","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02297","article-title":"Etiological spectrum and pattern of change in pituitary stalk thickening: Experience in 321 patients","volume":"104","author":"Zhou","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.868558","article-title":"Pituitary stalk thickening: Causes and consequences. the children\u2019s memorial health institute experience and literature review","volume":"13","author":"Moszczy\u0144ska","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00437-2","article-title":"Insights into non-classic and emerging causes of hypopituitarism","volume":"17","author":"Prodam","year":"2021","journal-title":"Nat Rev Endocrinol [Internet]"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4322\/acr.2020.228","article-title":"Primary pituitary tuberculosis","volume":"11","author":"Kumar","year":"2021","journal-title":"Autops Case Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30168","article-title":"Implications of deferred diagnosis of paediatric intracranial germ cell tumours","volume":"70","author":"Partenope","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-016-0736-z","article-title":"Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects","volume":"19","author":"Bellastella","year":"2016","journal-title":"Pituitary"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2411","article-title":"Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells","volume":"98","author":"Iwama","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","first-page":"dgac747","DOI":"10.1210\/clinem\/dgac747","article-title":"Approach to the patient: A case with an unusual cause of hypopituitarism","author":"Das","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3724","article-title":"Central diabetes insipidus in children and young adults: Etiological diagnosis and long-term outcome of idiopathic cases","volume":"99","author":"Di Iorgi","year":"2014","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1166953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T05:18:45Z","timestamp":1681795125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1166953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":40,"alternative-id":["10.3389\/fendo.2023.1166953"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1166953","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]},"article-number":"1166953"}}